Validation of Ventriject Determined Maximal Oxygen Uptake
- Conditions
- Healthy
- Registration Number
- NCT03504306
- Lead Sponsor
- University of Copenhagen
- Brief Summary
This study aims to validate the use of the Ventriject product to estimate VO2 max, through a non-physically active test using ECG, echoseismography and echosonography.
- Detailed Description
this study will be composed of the following tests:
* blood sample for measurement of blood values
* blood pressure measurement to rule out risks affiliated with maximal effort testing
* DXA body composition scanning
* Measurement on ECG, echosonography and echoseismography with accelerometer, microphone and ECG wires
* Measurements with phone (iPhone)
* VO2 max assessment by maximal oxygen uptake testing on a training bike, using online oxygenmeasurement equipment
* Hand-grip strength assessment
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
- healthy adults between 18 and 45 years of age
- current or previous cardiovascular disease
- chronic use of medicine
- pregnancy
- illnesses which prohibits the testing of maximal oxygen uptake
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparing how well the Ventriject software can estimate VO2 max 4 months data collection, although cross sectional VO2 max tested on bike with online software Ventriject will estimate VO2max based on ECG, echoseismography and echosonography obtained at rest
- Secondary Outcome Measures
Name Time Method comparing how well the measurements from the mobile phone test compare to the same measurements with accelerometer and echosonography 4 months data collection, although cross sectional comparison of ECG, echoseismography and echosonography obtained at rest to a measurement of movement (caused by heart contraction) by mobile phone, also at rest
Trial Locations
- Locations (1)
Xlab, Faculty of Health and Medical Sciences, University of Copenhagen
🇩🇰Copenhagen, Denmark